Track the Faes Farma, S.A. share price and the full directors' dealings record of the company, a listed issuer based in Spain. Shares are quoted on ES ES, under the supervision of CNMV. Operating in the Health Care sector, Faes Farma, S.A. has published 4 reports. Market capitalisation: €1.4bn. The latest transaction was disclosed on 7 July 2026 (Other). Among the most active insiders: MARIANO UCAR ANGULO. The full history is accessible without an account.
Analysts rate Faes Farma, S.A. Hold (neutral), based on 4 analysts. Average price target: €5.39.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
Faes Farma, S.A. is a Spanish pharmaceutical company focused on the research, development, and marketing of medications. It is listed on the Spanish stock market XMAD.